OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 116 filers reported holding OCULAR THERAPEUTIX INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,390,146 | +12.5% | 495,635 | +49.6% | 0.00% | 0.0% |
Q1 2024 | $3,014,394 | +177.7% | 331,252 | +36.1% | 0.00% | – |
Q4 2023 | $1,085,390 | +43.8% | 243,361 | +1.3% | 0.00% | – |
Q3 2023 | $754,574 | -50.2% | 240,310 | -18.1% | 0.00% | – |
Q2 2023 | $1,514,006 | -1.0% | 293,412 | +1.2% | 0.00% | – |
Q1 2023 | $1,528,591 | +104.2% | 290,055 | +8.9% | 0.00% | – |
Q4 2022 | $748,461 | -33.4% | 266,356 | -1.6% | 0.00% | – |
Q3 2022 | $1,123,000 | +12.2% | 270,610 | +8.7% | 0.00% | – |
Q2 2022 | $1,001,000 | -23.1% | 249,018 | -5.3% | 0.00% | – |
Q1 2022 | $1,302,000 | -28.5% | 263,040 | +0.7% | 0.00% | – |
Q4 2021 | $1,820,000 | -26.1% | 261,157 | +6.0% | 0.00% | – |
Q3 2021 | $2,464,000 | -20.5% | 246,337 | +12.7% | 0.00% | -100.0% |
Q2 2021 | $3,098,000 | -26.8% | 218,505 | -15.3% | 0.00% | 0.0% |
Q1 2021 | $4,232,000 | -36.8% | 257,917 | -20.2% | 0.00% | 0.0% |
Q4 2020 | $6,693,000 | +369.4% | 323,311 | +72.4% | 0.00% | – |
Q3 2020 | $1,426,000 | +1.4% | 187,500 | +11.2% | 0.00% | – |
Q2 2020 | $1,406,000 | +130.5% | 168,667 | +36.8% | 0.00% | – |
Q1 2020 | $610,000 | +29.0% | 123,332 | +3.1% | 0.00% | – |
Q4 2019 | $473,000 | +38.7% | 119,669 | +6.6% | 0.00% | – |
Q3 2019 | $341,000 | -26.5% | 112,272 | +6.5% | 0.00% | – |
Q2 2019 | $464,000 | +14.0% | 105,467 | +2.9% | 0.00% | – |
Q1 2019 | $407,000 | +3.0% | 102,477 | +3.3% | 0.00% | – |
Q4 2018 | $395,000 | -39.1% | 99,190 | +5.2% | 0.00% | – |
Q3 2018 | $649,000 | +2.0% | 94,294 | 0.0% | 0.00% | – |
Q2 2018 | $636,000 | +17.6% | 94,294 | +13.6% | 0.00% | – |
Q1 2018 | $541,000 | +75.1% | 83,018 | +19.8% | 0.00% | – |
Q4 2017 | $309,000 | -38.7% | 69,319 | -15.0% | 0.00% | – |
Q3 2017 | $504,000 | -33.2% | 81,586 | +0.2% | 0.00% | – |
Q2 2017 | $755,000 | -8.4% | 81,420 | -8.2% | 0.00% | – |
Q1 2017 | $824,000 | +38.5% | 88,736 | +24.9% | 0.00% | – |
Q4 2016 | $595,000 | +2.9% | 71,057 | -15.6% | 0.00% | – |
Q3 2016 | $578,000 | +108.7% | 84,199 | +50.6% | 0.00% | – |
Q2 2016 | $277,000 | -52.7% | 55,915 | -8.0% | 0.00% | – |
Q1 2016 | $586,000 | -7.7% | 60,747 | -10.4% | 0.00% | – |
Q4 2015 | $635,000 | -37.9% | 67,831 | -6.7% | 0.00% | – |
Q3 2015 | $1,023,000 | -9.5% | 72,724 | +35.2% | 0.00% | – |
Q2 2015 | $1,131,000 | +23.7% | 53,782 | +147.0% | 0.00% | – |
Q1 2015 | $914,000 | +124.6% | 21,776 | +26.0% | 0.00% | – |
Q4 2014 | $407,000 | +108.7% | 17,288 | +33.2% | 0.00% | – |
Q3 2014 | $195,000 | – | 12,979 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,861 | $79,675,000 | 100.00% |
Opaleye Management Inc. | 6,480,000 | $91,886,000 | 15.26% |
DELTEC ASSET MANAGEMENT LLC | 2,167,313 | $30,732,000 | 4.23% |
Kamunting Street Capital Management, L.P. | 624,201 | $8,851,000 | 3.58% |
GREAT POINT PARTNERS LLC | 919,887 | $13,044,000 | 2.74% |
Endurant Capital Management LP | 570,970 | $8,096,000 | 2.22% |
Rubric Capital Management LP | 2,156,542 | $30,580,000 | 1.92% |
Affinity Asset Advisors, LLC | 250,000 | $3,545,000 | 1.27% |
Altium Capital Management LP | 256,152 | $3,632,000 | 0.84% |
Ikarian Capital, LLC | 700,000 | $9,928,000 | 0.80% |